PARASAL SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Parasal Sodium, and when can generic versions of Parasal Sodium launch?
Parasal Sodium is a drug marketed by Panray and is included in one NDA.
The generic ingredient in PARASAL SODIUM is aminosalicylate sodium. There are three drug master file entries for this compound. Additional details are available on the aminosalicylate sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PARASAL SODIUM?
- What are the global sales for PARASAL SODIUM?
- What is Average Wholesale Price for PARASAL SODIUM?
Summary for PARASAL SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Patent Applications: | 6 |
| DailyMed Link: | PARASAL SODIUM at DailyMed |
US Patents and Regulatory Information for PARASAL SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-011 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
